Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Gynecol Oncol. 2017 Apr 6;145(3):420–425. doi: 10.1016/j.ygyno.2017.03.509

Table 2.

Prevalence and concordance of NY-ESO-1expression as determined by mRNA or immunohistochemistry.

# in Agreement % in Agreement
Positive Total Percent mRNA Protein mRNA Protein
mRNA Expression (RT-PCR or qRT-PCR) 260 1002 25.9%
Protein Expression (IHC) 232 874 26.5% 101 43.5%
Serology (ELISA) 131 689 19.0% 74 82 56.5% 62.6%

Prevalence and concordance of NY-ESO-1expression as determined by mRNA or immunohistochemistry.